Immucor Acquires Sentilus
The acquisition of Sentilus strengthens Immucor’s transfusion diagnostics portfolio with microarray-based, next-generation technology.
Read MorePosted by Steve Halasey | Oct 6, 2014 | Company News |
The acquisition of Sentilus strengthens Immucor’s transfusion diagnostics portfolio with microarray-based, next-generation technology.
Read MorePosted by Jenny Lower | Oct 1, 2014 | Hematology & Serology, Serology Instrumentation, Urinalysis & Toxicology |
As laboratories have changed, the field of serology has evolved to encompass new methods for testing blood serum, antigens, and antibodies.
Read MorePosted by Jenny Lower | Oct 1, 2014 | Cancer, Hematology & Serology, Serology Instrumentation |
In recent years, laboratories’ ability to detect and quantitate viruses through serology testing has significantly improved due to the use of molecular techniques.
Read MorePosted by Jenny Lower | Oct 1, 2014 | Blood Banking, Cancer, Hematology & Serology, Transfusion & Transplantation Tests |
Nearly 5 million people in the United States receive blood transfusions each year, mainly with donations collected, separated, and stored at blood banks. These days both private and institutional blood banks and biobanks are attracting significant amounts of investment, but they’re also facing challenges.
Read MorePosted by Jenny Lower | Oct 1, 2014 | Blood Banking, Cancer, Hematology & Serology, Molecular Diagnostics, Transfusion & Transplantation Tests |
A panel of experts speaking at Capitol Hill recently affirmed that the US blood supply has never been safer for patients needing transfusions.
Read More